SUSTALIV [Glucosamine sulfate + Meloxicam] 1500 +15 mg Granules for oral solution

Instructions for the medical use of the medicinal product

SUSTALIV

Tradename

Sustaliv, Сусталив

International non-proprietary name or generic name

Glucosamine + Meloxicam, Глюкозамин + Мелоксикам Composition

Each sachet contains:

active substances: glucosamine sulfate 1500 mg, meloxicam 15 mg;

excipients: colloidal silicon dioxide, sodium lauryl sulfate, PEG 4000, sodium saccharin, anhydrous citric acid, sorbitol 70.0%, PVP K 30, aspartame, lemon flavor, sugar.

Dosage form

Granules for oral solution. Pharmacotherapeutic group Tissue regeneration stimulant

Non-steroidal anti-inflammatory drug (NSAID)

Pharmacological properties

Glucosamine is the main building material for connective tissue. Anti-inflammatory agent, compensates for the endogenous deficiency of glucosamine, increases the permeability of the joint capsule, restores enzymatic processes in the cells of the synovial membrane and articular cartilage. Promotes the fixation of sulfur in the process of synthesis of chondroitinsulfuric acid, facilitates the normal deposition of calcium in bone tissue, inhibits the development of degenerative processes in the joints, restores their function, reducing joint pain.

Meloxicam is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. Inhibits the synthesis of prostaglandins as a result of selective suppression of the enzymatic activity of cyclooxygenase-2 (COX-2), which is involved in the biosynthesis of prostaglandins in the area of inflammation. When used in high doses, long-term use and individual characteristics of the organism, COX-2 selectivity decreases. Suppresses the synthesis of prostaglandins in the area of inflammation to a greater extent than in the gastric mucosa or kidneys, which is associated with a relatively selective inhibition of COX-2. Rarely causes erosive and ulcerative changes in the gastrointestinal tract. To a lesser extent, meloxicam acts on cyclooxygenase-1 (COX-1), which is involved in the synthesis of prostaglandins that protect the mucous membrane of the gastrointestinal tract (GIT) and are involved in the regulation of blood flow in the kidneys.

Indications for use

Osteoarthritis of the peripheral joints and spine, osteochondrosis, rheumatoid arthritis, ankylosing spondylitis (Bekhterev's disease), degenerative joint diseases accompanied by pain.

Contraindications

                 individual hypersensitivity to active substances and other components of the drug;

                 severe renal failure, progressive kidney disease incl. confirmed hyperkalemia;

                 severe liver failure or active liver disease;

                 decompensated heart failure;

                 erosive and ulcerative changes in the mucous membrane of the stomach or duodenum, active gastrointestinal bleeding;

                 cerebrovascular bleeding or other bleeding;

                 hypersensitivity to non-steroidal anti-inflammatory drugs, acetylsalicylic acid;

                 pregnancy, breastfeeding period;

                 children and adolescents up to 18 years of age.

Method of administration and dosage Inside during meals, preferably with breakfast. 1 sachet 1 time per day.

Preparation: pour the contents of the sachet into a glass (200 ml) of chilled boiled water, stir and drink.

Do not exceed the recommended dose unless directed by a doctor.

Special instructions and precautions

Before using the drug, consult a doctor!

Caution should be exercised when using the drug in patients with a history of gastric ulcer and 12 duodenal ulcer, Crohn's disease, ulcerative colitis, as well as in patients on anticoagulant therapy. These patients have an increased risk of erosive and ulcerative lesions of the gastrointestinal tract. Caution should be exercised and renal function indicators should be monitored when using the drug in elderly patients, patients with chronic heart failure with symptoms of circulatory failure, hypertension, in patients with cirrhosis of the liver, as well as in patients with hypovolemia as a result of surgical interventions.

The drug contains aspartame, so patients with phenylketonuria should not take this drug.

Influence on the ability to drive vehicles and mechanisms

During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.

Interaction with other medicinal products

With the simultaneous use of glucosamine

                 with warfarin, the effect of warfarin is enhanced, which can increase the risk of serious bruising and bleeding;

                 with anticancer drugs, the effect of these drugs is reduced;

                 tetracycline, penicillin and chloamphenicol, glucosamine enhances the absorption of tetracycline from the gastrointestinal tract and reduces - penicillin and chloramphenicol.

With the simultaneous use of meloxicam

                 with other non-steroidal anti-inflammatory drugs (as well as with acetylsalicylic acid), the risk of erosive and ulcerative lesions and bleeding of the gastrointestinal tract increases;

                 with antihypertensive drugs, it is possible to reduce the effectiveness of the latter;

                 with lithium preparations, it is possible to develop lithium accumulation and increase its toxic effect (it is recommended to control the concentration of lithium in the blood);

                 with methotrexate, the side effect of the latter on the hematopoietic system increases (the risk of anemia and leukopenia, periodic complete blood counts are indicated).

                 with diuretics and with cyclosporine, the risk of developing renal failure increases.

                 with intrauterine contraceptives, it is possible to reduce the effectiveness of the latter;

                 with anticoagulants (heparin, ticlopidine, warfarin), as well as with thrombolytic drugs (streptokinase, fibrinolysin), the risk of bleeding increases (periodic monitoring of blood coagulation parameters is necessary);

                 with colestyramine, the excretion of the drug from the body is accelerated;

                 With selective serotonin reuptake inhibitors, the risk of developing gastrointestinal bleeding increases.

Side effect

                 nausea, vomiting, dyspepsia, heaviness and pain in the abdomen, constipation, flatulence, diarrhea, belching, esophagitis, gastroduodenal ulcer, hidden or macroscopic gastrointestinal bleeding;

                 dizziness, drowsiness, headache;

                 erythema, itching;

                 rarely, transient changes in liver function parameters. If any of the side effects listed in the instructions get worse, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose

Symptoms: nausea, vomiting, epigastric pain, gastrointestinal bleeding, impaired consciousness, acute renal failure, liver failure.

Treatment: there is no specific antidote; in case of an overdose of the drug, gastric lavage should be performed, activated charcoal should be taken (within the next hour), symptomatic therapy.

Storage conditions

Store in a dry and dark place, at a temperature not exceeding 25°C.

Keep out of the reach of children!

Shelf life

3 years. Do not use aſter the expiry date stated on the packaging.

Vacation conditions Dispensed by prescription.

Release form

5 sachets of 5 g together with instructions for use in a cardboard box.

© 2022. Live Medicine - Pharmaceutical company